VEGFA and age-related macular degeneration: AMD patients treated with intravitreal ranibizumab or aflibercept displayed a reduction in aqueous humor levels of inflammatory factors and VEGF-A, which accompanied improvements in visual acuity and central macular thickness (Motohashi et al., 2017).